IKNA - Ikena Oncology Inc
IEX Last Trade
1.71
0.020 1.170%
Share volume: 30,386
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.69
0.02
1.18%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-07 | 2023-03-14 | 2023-05-15 | 2023-08-10 | 2023-11-09 | 2024-03-12 | 2024-05-13 | |
| Assets | |||||||||
| Total Assets | 211.184 M | 190.468 M | 172.259 M | 152.401 M | 171.764 M | 215.335 M | 192.092 M | 172.782 M | |
| Current Assets | 199.145 M | 177.978 M | 160.010 M | 141.178 M | 160.646 M | 200.634 M | 178.662 M | 161.166 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 6.335 M | 3.617 M | 3.063 M | 3.365 M | 3.334 M | 3.701 M | 3.197 M | 3.817 M | |
| Short Term Investments | 6.335 M | 3.617 M | 3.063 M | 3.365 M | 3.334 M | 3.701 M | 3.197 M | 3.817 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 192.810 M | 174.361 M | 156.947 M | 137.813 M | 157.312 M | 196.933 M | 175.465 M | 157.349 M | |
| Total Non-current Assets | 12.039 M | 12.490 M | 12.249 M | 11.223 M | 11.118 M | 14.701 M | 13.430 M | 11.616 M | |
| Property Plant Equipment | 2.950 M | 3.115 M | 3.205 M | 3.126 M | 2.875 M | 2.633 M | 2.335 M | 864.000 K | |
| Other Assets | 9.089 M | 9.375 M | 9.044 M | 8.097 M | 8.243 M | 12.068 M | 11.095 M | 10.752 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 211.184 M | 190.468 M | 172.259 M | 152.401 M | 171.764 M | 215.335 M | 192.092 M | 172.782 M | |
| Total liabilities | 36.816 M | 31.680 M | 25.290 M | 17.379 M | 15.064 M | 28.146 M | 22.335 M | 17.435 M | |
| Total current liabilities | 28.514 M | 25.040 M | 21.503 M | 13.950 M | 12.008 M | 19.271 M | 14.205 M | 10.169 M | |
| Accounts Payable | 4.092 M | 2.361 M | 2.093 M | 2.759 M | 1.772 M | 3.950 M | 2.066 M | 1.909 M | |
| Other liabilities | 3.819 M | 2.502 M | 0.000 | 0.000 | 0.000 | 852.000 K | 950.000 K | 964.000 K | |
| Current long term debt | 1.880 M | 1.894 M | 1.907 M | 1.920 M | 1.937 M | 3.469 M | 3.558 M | 3.443 M | |
| Long term debt | 4.483 M | 4.138 M | 3.787 M | 3.429 M | 3.056 M | 8.023 M | 7.180 M | 6.302 M | |
| Other liabilities | 3.819 M | 2.502 M | 0.000 | 0.000 | 0.000 | 852.000 K | 950.000 K | 964.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 174.368 M | 158.788 M | 146.969 M | 135.022 M | 156.700 M | 187.189 M | 169.757 M | 155.347 M | |
| Common stock | 36.161 M | 36.257 M | 36.260 M | 36.257 M | 39.293 M | 43.438 M | 47.952 M | 48.258 M | |
| Retained earnings | -182.784 M | -200.122 M | -214.219 M | -228.438 M | -245.553 M | -262.896 M | -282.385 M | -298.531 M |